Metabolites
Associations Between Systemic Inflammatory Markers, Metabolic Dysfunction, and Liver Fibrosis Scores in Patients with MASLD.
Ragaey Ahmad Eid, Ahmed Moheyeldien Hamed, Sara O Elgendy, Khalid M Orayj, Ahmed R N Ibrahim, Ahmed M Abdel Hamied, Engy A Wahsh, Maha Youssif, Hoda Rabea, Yasmin M Madney, Dina Attia, Shaymaa Nafady
Published: 202510.3390/metabo16010025
Abstract
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a global health challenge due to its complex pathophysiological processes. Systemic inflammation may profoundly affect disease progression, but the correlatio…
Preview only. Read the full abstract at the source